QRx Pharma said chief executive John Holaday has resigned and will be succeeded immediately by Edward Rudnic, who has been the company’s chief operating officer since early 2012.
QRx Pharma said chief executive John Holaday has resigned and will be succeeded immediately by Edward Rudnic, who has been the company’s chief operating officer since early 2012.
“This change in leadership was set by mutual agreement to address the challenges facing the company," chairman Peter Farrell said in a statement to the Australian Stock Exchange.
